TNF and chronic granulomatous disease: To assess the role of TNFα in vivo we delivered neutralizing antibody to CGD mice at 20 and 44 hours after i.p. zymosan treatment and collected peritoneal lavage to assess MoMac phenotype at 72h post-zymosan (Figure 5A).